OncoRes: Shedding Light on Breast Cancer Tumor Removal


The treatment of breast cancer today commonly entails repeat breast conserving surgeries due to imprecise methods of locating and measuring tumors during surgery. These lead to unnecessary expenditures of over $1 billion across the US and Europe. To help surgeons reduce these follow-up surgeries, OncoRes Medical is developing a probe that detects residual tumor within the surgical cavity in real time using OCT-E.

Breast cancer is the most common type of cancer in women across the world, impacting nearly a quarter of a million women in the US annually and killing roughly 20% of those diagnosed, according to the CDC.

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to MedTech Strategist:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to MedTech Strategist
Subscribe to ELITE Strategist

Become an ELITE Strategist and unlock access to both MedTech Strategist and MTS Market Pathways.

Subscribe to Elite


We're here to help! Please contact us at: